The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Role of Benign Joint Hypermobility in Functional Pain Disorders

The Role of Benign Joint Hypermobility in Functional Pain Disorders

October 3, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

shutterstock_HipBone_500x270Physicians diagnose benign joint hypermobility (BJH) syndrome in individuals with musculoskeletal symptoms who also have excessive joint laxity. In particular, adolescents with functional gastrointestinal (GI) disorders are often also diagnosed with joint hypermobility, as well as fibromyalgia. This finding has led some experts to suggest that functional GI disorders and BJH may share an underlying pathophysiology. Therefore, they recommend that individuals with complex functional GI disorders should be screened for joint hypermobility and fibromyalgia, as well as co-morbid symptoms, such as sleep disturbances, migraines and autonomic dysfunction.1 Thus far, however, studies into the role of autonomic dysfunction in BJH have suggested that although postural orthostatic tachycardia syndrome (POTS) is common in adolescents with functional GI disorders, it’s not common in children with hypermobility. These findings have left physicians puzzled as to the relationship between joint hypermobility and autonomic dysfunction.

You Might Also Like
  • Strides in Recognition and Management of Joint Hypermobility Syndrome
  • FDA Warns of Severe Joint Pain Risk with DPP-4 Diabetes Drugs
  • Nonsurgical Treatments Can Relieve Pain, Improve Hand Function in Thumb Carpometacarpal Joint Osteoarthritis
Also By This Author
  • Do Bisphosphonates Increase Risk of Carpal Tunnel Syndrome?

Recently, researchers have tried to dig deeper into the unresolved issue of the role of BJH in the development of autonomic symptoms and comorbidities. To answer this question, Gisela Chelimsky, MD, from the Medical College of Wisconsin in Milwaukee, and colleagues compared children with chronic functional pain disorders and BJH with a similar cohort of patients with chronic functional pain disorders in the absence of BJH. The direct comparison allowed the investigators to determine if patients with BJH have more autonomic dysfunction than patients who present with similar complaints but do not have BJH. The retrospective chart review included a total of 21 female patients seen in a pediatric neurogastroenterology and autonomic clinic. Eleven of the subjects had BJH, as confirmed by genetics consultation and/or meeting the classic Brighton criteria. The authors note that, in general, patients who are referred to this clinic have a variety of autonomic complaints, migraines, nausea and fatigue, as well as functional GI disorders.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both groups had a similar age of symptom onset: 15.6 years for those with BJH and 15.4 years for those without BJH. Most of the children in both groups presented with migraine or GI complaints as their chronic functional pain. Other complaints included chronic fatigue, lightheadedness, dizziness, fainting more than three times in their lifetimes and delayed onset of sleep. None of the patients had fibromyalgia as diagnosed by greater than 10 tender points. All told, the total number of co-morbid symptoms did not differ between the two groups.

The investigators evaluated the patients for tilt-table diagnoses of POTS, syncope, orthostatic intolerance symptoms that did not meet the criteria of POTS, orthostatic hypotension, baseline heart rate, peak heart rate in first 10 minutes of head-up tilt and sudomotor index. They then quantified the autonomic testing results using a composite autonomic severity score. The researchers found that neither the individual measurements nor the composite autonomic severity score differed between the two cohorts.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, Soft Tissue Pain Tagged With: benign joint hypermobility, comorbidities, Fibromialgia, gastrointestinal, joint, Pain

You Might Also Like:
  • Strides in Recognition and Management of Joint Hypermobility Syndrome
  • FDA Warns of Severe Joint Pain Risk with DPP-4 Diabetes Drugs
  • Nonsurgical Treatments Can Relieve Pain, Improve Hand Function in Thumb Carpometacarpal Joint Osteoarthritis
  • The Role of the Physician Assistant in the Treatment of Pain

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.